Literature DB >> 12955667

Buruli ulcer: a systemic disease.

Nina Pszolla1, Michael Robindra Sarkar, Wolf Strecker, Peter Kern, Lothar Kinzl, Wayne M Meyers, Françoise Portaels.   

Abstract

We studied a 4-year-old boy from Angola who presented with 2 cutaneous ulcerations of the right hip and osteomyelitis of the left knee and right ankle. Mycobacterium ulcerans disease was confirmed by direct smear examination and by polymerase chain reaction. The patient was treated with antimycobacterial drugs, repeated surgical debridement, skin grafting, and daily hyperbaric oxygenation. Despite significant improvement of the local lesions in response to hyperbaric oxygenation, swelling of the right knee, without associated skin lesions, was noted. Radiological evaluation and open biopsy revealed extensive metaphyseal osteomyelitis of the right distal femur. A 99technetium bone scan revealed an additional focus in the diaphysis of the left humerus, without soft-tissue involvement. This case documents, for the first time (to our knowledge), the systemic spread of M. ulcerans, with subsequent multifocal osteomyelitis and secondary involvement of soft tissues and supports the hypothesis that low tissue oxygen levels promote hematogenous spread of M. ulcerans. Sickle cell anemia, with associated microthrombosis and microinfarction, may have contributed to tissue hypoxia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12955667     DOI: 10.1086/377170

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  14 in total

Review 1.  Treating Mycobacterium ulcerans disease (Buruli ulcer): from surgery to antibiotics, is the pill mightier than the knife?

Authors:  Paul J Converse; Eric L Nuermberger; Deepak V Almeida; Jacques H Grosset
Journal:  Future Microbiol       Date:  2011-10       Impact factor: 3.165

Review 2.  Control of neglected tropical diseases needs a long-term commitment.

Authors:  Yaobi Zhang; Chad MacArthur; Likezo Mubila; Shawn Baker
Journal:  BMC Med       Date:  2010-10-29       Impact factor: 8.775

3.  Mycobacterium ulcerans triggers T-cell immunity followed by local and regional but not systemic immunosuppression.

Authors:  Alexandra G Fraga; Andrea Cruz; Teresa G Martins; Egídio Torrado; Margarida Saraiva; Daniela R Pereira; Wayne M Meyers; Françoise Portaels; Manuel T Silva; António G Castro; Jorge Pedrosa
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

4.  Severe multifocal form of buruli ulcer after streptomycin and rifampin treatment: comments on possible dissemination mechanisms.

Authors:  Ghislain Emmanuel Sopoh; Ange Dodji Dossou; Luc Valère Brun; Yves Thierry Barogui; Jean Gabin Houézo; Dissou Affolabi; Séverin Y Anagonou; Roch Christian Johnson; Luc Kestens; Françoise Portaels
Journal:  Am J Trop Med Hyg       Date:  2010-08       Impact factor: 2.345

Review 5.  Buruli Ulcer, a Prototype for Ecosystem-Related Infection, Caused by Mycobacterium ulcerans.

Authors:  Dezemon Zingue; Amar Bouam; Roger B D Tian; Michel Drancourt
Journal:  Clin Microbiol Rev       Date:  2017-12-13       Impact factor: 26.132

6.  Challenges Associated with Management of Buruli Ulcer/Human Immunodeficiency Virus Coinfection in a Treatment Center in Ghana: A Case Series Study.

Authors:  Joseph Tuffour; Evelyn Owusu-Mireku; Marie-Therese Ruf; Samuel Aboagye; Grace Kpeli; Victor Akuoku; Janet Pereko; Albert Paintsil; Kofi Bonney; William Ampofo; Gerd Pluschke; Dorothy Yeboah-Manu
Journal:  Am J Trop Med Hyg       Date:  2015-06-08       Impact factor: 2.345

7.  What does detection of Mycobacterium ulcerans DNA in the margin of an excised Buruli ulcer lesion tell us?

Authors:  Simona Rondini; Ernestina Mensah-Quainoo; Thomas Junghanss; Gerd Pluschke
Journal:  J Clin Microbiol       Date:  2006-08-23       Impact factor: 5.948

8.  Vaccine-Specific Immune Responses against Mycobacterium ulcerans Infection in a Low-Dose Murine Challenge Model.

Authors:  Brendon Y Chua; Timothy P Stinear; Kirstie M Mangas; Andrew H Buultjens; Jessica L Porter; Sarah L Baines; Estelle Marion; Laurent Marsollier; Nicholas J Tobias; Sacha J Pidot; Kylie M Quinn; David J Price; Katherine Kedzierska; Weiguang Zeng; David C Jackson
Journal:  Infect Immun       Date:  2020-02-20       Impact factor: 3.441

9.  Response to treatment in a prospective cohort of patients with large ulcerated lesions suspected to be Buruli Ulcer (Mycobacterium ulcerans disease).

Authors:  Kapay Kibadi; Marleen Boelaert; Alexandra G Fraga; Makanzu Kayinua; Adhemar Longatto-Filho; Jean-Bedel Minuku; Jean-Baptiste Mputu-Yamba; Jean-Jacques Muyembe-Tamfum; Jorge Pedrosa; Jean-Jacques Roux; Wayne M Meyers; Françoise Portaels
Journal:  PLoS Negl Trop Dis       Date:  2010-07-06

10.  Mycolactone is responsible for the painlessness of Mycobacterium ulcerans infection (buruli ulcer) in a murine study.

Authors:  Junichiro En; Masamichi Goto; Kazue Nakanaga; Michiyo Higashi; Norihisa Ishii; Hajime Saito; Suguru Yonezawa; Hirofumi Hamada; Pamela L C Small
Journal:  Infect Immun       Date:  2008-03-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.